PROCEPT BioRobotics Corp

PRCTReported to SECin USCIK 0001588978Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 12. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 12
Form 4 lines at PROCEPT BioRobotics Corp, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Waters KevinEVP, CFOOpen-market sell$7,815373 sharesSep 10, 2026Waters KevinEVP, CFO$7,815Sell · Sep 10Open-market sell373Sep 10, 2026
Nouri AlalehEVP, CLO, CORP. SEC.Open-market sell$6,223297 sharesSep 10, 2026Nouri AlalehEVP, CLO, CORP. SEC.$6,223Sell · Sep 10Open-market sell297Sep 10, 2026
Templin Barry LEVP, Chief Technology OfficerOpen-market sell$7,815373 sharesSep 10, 2026Templin Barry LEVP, Chief Technology Officer$7,815Sell · Sep 10Open-market sell373Sep 10, 2026
Nouri AlalehEVP, CLO, CORP. SEC.Awardnothing paid31,773 sharesAug 14, 2026Nouri AlalehEVP, CLO, CORP. SEC.nothing paidAward · Aug 14Award31,773Aug 14, 2026
Nouri AlalehEVP, CLO, CORP. SEC.Awardnothing paid22,965 sharesAug 14, 2026Nouri AlalehEVP, CLO, CORP. SEC.nothing paidAward · Aug 14Award22,965Aug 14, 2026